Kerwin E, Ferguson GT. An overview of glycopyrrolate/eFlow® CS in COPD. Expert Rev Respir Med. 2018 Jun;12(6):447-459. Available from: http://dx.doi.org/10.1080/17476348.2018.1476853
When the above article was first published online, contains visual artefacts and errors in two n values. Below is the corrected .
*p < 0.05; **p < 0.01 versus placebo b.i.d., twice daily; CI, confidence interval; GLY, glycopyrrolate; LSM, least squares mean; MCID, minimal clinically important difference; q.d., once daily; SE, standard error; SGRQ, St George’s respiratory questionnaire; TIO, tiotropium.
The authors apologise for this error.